Pricing & policy · first seen 12h ago, updated 12h ago
What J&J’s Spravato patent win could mean for psychedelic drugs
As more psychedelic drugs move toward market, developers are testing how far patent protection can extend around familiar compounds.
Summary from PharmaVoice.